Elefante Mark B Acquires 2,418 Shares of Danaher Corporation $DHR

Elefante Mark B lifted its holdings in shares of Danaher Corporation (NYSE:DHR) by 12.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,530 shares of the conglomerate’s stock after buying an additional 2,418 shares during the quarter. Danaher comprises 2.7% of Elefante Mark B’s investment portfolio, making the stock its 16th biggest position. Elefante Mark B’s holdings in Danaher were worth $4,269,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of DHR. Norges Bank bought a new position in shares of Danaher in the second quarter worth $1,979,503,000. Viking Global Investors LP lifted its holdings in Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. Generation Investment Management LLP boosted its stake in Danaher by 56.2% in the 2nd quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock worth $980,914,000 after purchasing an additional 1,787,522 shares during the period. Primecap Management Co. CA grew its holdings in Danaher by 924.2% during the 2nd quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock valued at $244,815,000 after buying an additional 1,118,318 shares in the last quarter. Finally, Vanguard Group Inc. increased its position in shares of Danaher by 1.3% during the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock valued at $12,004,424,000 after buying an additional 788,499 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

DHR opened at $211.00 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $149.04 billion, a P/E ratio of 41.87, a PEG ratio of 2.82 and a beta of 0.91. The stock has a 50-day moving average price of $227.19 and a 200-day moving average price of $215.69. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $2.14 EPS. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is currently 25.40%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Guggenheim raised their price target on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. Argus set a $265.00 price objective on Danaher in a research report on Wednesday, January 14th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.